Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reifenberger

Showing results (381-390 of 562) with videos related to

Pageof 57
Sort By:
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>Abigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 13, 2012
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of gliomaMarion Rapp, Alexander Heinzel, Norbert Galldiks, et al.
Cancers|July 9, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like CellsSuad Yusuf, Philippe Aretz, Ann-Christin Nickel, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastomaKatharina Seystahl, Bettina Hentschel, Sarah Loew, et al.
Cancer Research|January 25, 2019
A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical ImplicationsMatthieu Gobin, Petr V Nazarov, Rolf Warta, et al.
Neuro-Oncology Practice|July 19, 2021
Chemotherapy for adult patients with spinal cord gliomasDorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Frontiers in Oncology|May 3, 2021
Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR TrialAlex Vils, Marta Bogowicz, Stephanie Tanadini-Lang, et al.
Brain : a Journal of Neurology|April 9, 2010
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alphaSascha Seidel, Boyan K Garvalov, Valtteri Wirta, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2020
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomideKerstin Berger, Bernd Turowski, Jörg Felsberg, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.
Pageof 57

Showing results (381-390 of 562) with videos related to

Sort By:
Pageof 57
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>Abigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 13, 2012
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of gliomaMarion Rapp, Alexander Heinzel, Norbert Galldiks, et al.
Cancers|July 9, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like CellsSuad Yusuf, Philippe Aretz, Ann-Christin Nickel, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastomaKatharina Seystahl, Bettina Hentschel, Sarah Loew, et al.
Cancer Research|January 25, 2019
A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical ImplicationsMatthieu Gobin, Petr V Nazarov, Rolf Warta, et al.
Neuro-Oncology Practice|July 19, 2021
Chemotherapy for adult patients with spinal cord gliomasDorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Frontiers in Oncology|May 3, 2021
Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR TrialAlex Vils, Marta Bogowicz, Stephanie Tanadini-Lang, et al.
Brain : a Journal of Neurology|April 9, 2010
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alphaSascha Seidel, Boyan K Garvalov, Valtteri Wirta, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2020
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomideKerstin Berger, Bernd Turowski, Jörg Felsberg, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.
Pageof 57